Jansen A G, Noordzij J G, Bröcker-Vriends A H, van Dongen J J, van Tol M J, Bredius R G
Erasmus Medisch Centrum, Rotterdam.
Ned Tijdschr Geneeskd. 2004 May 22;148(21):1053-6.
X-linked agammaglobulinaemia (XLA) is a primary immunodeficiency caused by a mutation in the gene encoding Bruton's tyrosine kinase (BTK). The classical presentation of XLA consists of the almost complete absence of B-lymphocytes and immunoglobulins in the peripheral blood leading to severe, mainly bacterial, upper and lower respiratory-tract infections already in early childhood. Irrespective of the kind of BTK-gene mutation the phenotype of XLA can be very diverse. Two 9-year-old cousins with the same BTK-gene mutation illustrate this phenotypical diversity. One boy had a classical presentation and was on maintenance treatment with intravenous immunoglobulins and prophylactic antibiotics to control his infections. Without any prophylactic treatment, his cousin had no abnormal infectious course despite very low B-lymphocyte counts and immunoglobulin levels in the blood. The mechanisms underlying the phenotypical diversity of XLA have not been clarified. Gene polymorphisms affecting the innate immune system may play a role.
X连锁无丙种球蛋白血症(XLA)是一种由编码布鲁顿酪氨酸激酶(BTK)的基因突变引起的原发性免疫缺陷病。XLA的典型表现为外周血中几乎完全缺乏B淋巴细胞和免疫球蛋白,导致幼儿期就出现严重的、主要是细菌性的上、下呼吸道感染。无论BTK基因突变的类型如何,XLA的表型都可能非常多样。两个患有相同BTK基因突变的9岁表兄弟说明了这种表型多样性。一个男孩有典型表现,正在接受静脉注射免疫球蛋白和预防性抗生素的维持治疗以控制感染。他的表弟在没有任何预防性治疗的情况下,尽管血液中的B淋巴细胞计数和免疫球蛋白水平非常低,但没有异常的感染病程。XLA表型多样性的潜在机制尚未阐明。影响先天免疫系统的基因多态性可能起作用。